663
Views
0
CrossRef citations to date
0
Altmetric
COMMENTARY

MARIPOSA: Can Amivantamab and Lazertinib Replace Osimertinib in the Front-Line Setting?

& ORCID Icon
Pages 41-47 | Received 08 Dec 2023, Accepted 19 Mar 2024, Published online: 12 Apr 2024